SCHEMBL3404286

SCHEMBL3404286

CCOC(=O)c1c(-c2ccccc2F)nsc1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 1/20 0.48
JAK3 P52333 1/20 0.48
ALOX5 P09917 3/20 0.46
ALDH1A1 P00352 5/20 0.45
NPSR1 Q6W5P4 4/20 0.45
HPGD P15428 4/20 0.45
HSD17B10 Q99714 1/20 0.45
NPC1 O15118 5/20 0.43
MAPT P10636 5/20 0.43
RAB9A P51151 4/20 0.43
KDM4E B2RXH2 2/20 0.43
PKM P14618 1/20 0.43
MAPK1 P28482 1/20 0.43
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42
CA14 Q9ULX7 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3404515 0.81 ADORA3 (0.58) ALDH1A1NPSR1HPGDHSD17B10NPC1
SCHEMBL3407583 0.78 ALDH1A1 (0.64) ALOX5ALDH1A1NPSR1HPGDNPC1
SCHEMBL13615450 0.77 TRPM8 (0.53) JAK2JAK3ALDH1A1NPSR1HPGD
SCHEMBL8787890 0.76 JAK2 (0.54) JAK2JAK3ALOX5ALDH1A1NPSR1
SCHEMBL2924198 0.76 GPBAR1 (0.58) ALOX5ALDH1A1NPSR1HPGDNPC1
SCHEMBL22730639 0.76 ALOX5 (0.53) JAK2JAK3ALOX5ALDH1A1NPSR1
SCHEMBL5065916 0.74 JAK2 (0.52) JAK2JAK3ALOX5ALDH1A1NPC1
SCHEMBL3403428 0.74 JAK2 (0.47) JAK2JAK3ALOX5ALDH1A1NPSR1
SCHEMBL3404102 0.74 JAK2 (0.44) JAK2JAK3ALOX5ALDH1A1NPSR1
SCHEMBL20080016 0.74 ALDH1A1 (0.49) ALDH1A1NPSR1HPGDNPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9387200-B2 Isothiazole-pyridine derivatives as modulators of HIF (hypoxia inducible factor) activity FIBROGEN, INC. (US) 2016-07-12 US disclosed
US-20150209336-A1 ISOTHIAZOLE-PYRIDINE DERIVATIVES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY FIBROGEN, INC. 2015-07-30 US disclosed
US-8952160-B2 Isothiazole-pyridine derivatives as modulators of HIF (hypoxia inducible factor) activity FIBROGEN, INC. (US) 2015-02-10 US disclosed
EP-2252619-B1 ISOTHIAZOLE-PYRIDINE DERIVATIVES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY FIBROGEN INC (US) 2013-10-09 EP disclosed
US-20100330199-A1 ISOTHIAZOLE-PYRIDINE DERIVATES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY FIBROGEN, INC. 2010-12-30 US disclosed
EP-2252619-A1 ISOTHIAZOLE-PYRIDINE DERIVATIVES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY Fibrogen, Inc. (US) 2010-11-24 EP disclosed
WO-2009089547-A1 ISOTHIAZOLE-PYRIDINE DERIVATIVES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY FIBROGEN, INC. (US) 2009-07-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100330199-A1 ISOTHIAZOLE-PYRIDINE DERIVATES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY HIF1A, HIF1AN, EGLN3 JAK2 1596/4885JAK3 3056/4885ALOX5 3556/4885
US-20150209336-A1 ISOTHIAZOLE-PYRIDINE DERIVATIVES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY HIF1A, HIF1AN, EGLN3 JAK2 1412/4885JAK3 3031/4885ALOX5 3636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.